Catalyst Event
Bristol-Myers Squibb Co (BMY) · Earnings Release
From KEDI Global Longevity Bio Index (KGLB)
4/30/2026, 12:00:00 AM
Bristol-Myers Squibb is scheduled to report its Q1 2026 financial results on April 30, 2026, with analysts forecasting EPS of $1.45. High impact is estimated as quarterly earnings are major market catalysts scheduled.
Korean Translation
브리스톨 마이어스 스큅의 2026년 4월 30일 1분기 실적 발표가 예정되어 있으며, 분석가들은 주당순이익(EPS) 1.45달러를 전망함. 분기 실적은 주요 시장 촉매제이므로 높은 영향이 예상됨. 2026년 4월 30일 실적 발표 예정됨.
Related Recent Events
Takeda Pharmaceutical Co Ltd (TAK) · Other
Current President & CEO Christophe Weber is scheduled to retire and will be succeeded by CEO-elect Julie Kim on June 24, 2026. This leadership change is estimated to have a high price impact of at least 10% due to potential shifts in corporate strategy and is expected.
6/24/2026, 12:00:00 AM
Biogen Inc (BIIB) · Other
U.S. FDA decision on the supplemental application for LEQEMBI IQLIK on 2026-05-24; price impact is estimated to be ≥10% as a major drug catalyst, expected.
5/24/2026, 12:00:00 AM
Medpace Holdings Inc (MEDP) · Other
Annual Meeting of Stockholders on May 15, 2026. Annual meetings usually have minor impact on stock price, estimated at >1%, scheduled.
5/15/2026, 12:00:00 AM
Takeda Pharmaceutical Co Ltd (TAK) · Earnings Release
Full-year financial results for fiscal year 2025 are scheduled for May 13, 2026. This annual earnings release is estimated to have a medium price impact of at least 5% based on historical volatility and is expected.
5/13/2026, 12:00:00 AM
Viatris Inc (VTRS) · Earnings Release
Viatris is scheduled to report its first quarter 2026 financial results on May 7, 2026, with a webcast for investors scheduled. Earnings releases typically result in 5% or more price impact, so a Medium impact is expected.
5/7/2026, 12:00:00 AM
RELX PLC (RELX) · Other
The ex-dividend date for the proposed final dividend of 48.0 pence per share for the 2025 financial year is May 7, 2026. The payment date is June 18, 2026. Low importance is estimated based on typical dividend yield impact, scheduled.
5/7/2026, 12:00:00 AM